Director Head of Infectious Diseases 3
Shionogi&Co., Ltd., Japan
Disclosure(s): SHIONOGI and CO., LTD.: Stocks/Bonds (Private Company)
I am Keita Fukao, the Director, Head of the Infectious Disease 3 at the Pharmaceutical Research Division of Shionogi & Co., Ltd. From 2005 to 2013, I was engaged in pharmacological research in the area of metabolic diseases, creating anti-atherosclerotic drug candidates. Since 2014, I have been working on drug discovery in the infectious diseases field, and I am responsible for research on therapeutic drugs as a study director for drug discovery for acute respiratory viral infections such as influenza and COVID-19. I have published our research results in many conferences and papers regarding these topics. As a director of the pharmacology research group in the field of viruses, I continue to lead research activities aimed at creating therapeutic drugs to address unmet healthcare needs.